Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „concomitant“
Suchtreffer
Begriffe & Kennungen
Brilique · 4.5 · P-gp substrates (including digoxin, cyclosporine) Concomitant administration of ticagrelor increased the digox
Eintrag öffnenBrilique · 4.8 · 56 Age, sex, weight, race, geographic region, concurrent conditions, concomitant therapy and medical history,
Eintrag öffnenBrilique · 4.8 · Age, sex, weight, race, geographic region, concurrent conditions, concomitant therapy and medical history, inc
Eintrag öffnenBrilique · 4.8 · Age, sex, weight, race, geographic region, concurrent conditions, concomitant therapy and medical history, inc
Eintrag öffnenBrintellix · 4.3 · Concomitant use with nonselective monoamine oxidase inhibitors (MAOIs) or selective MAO-A inhibitors (see sect
Eintrag öffnenBrintellix · 4.3 · Concomitant use with nonselective monoamine oxidase inhibitors (MAOIs) or selective MAO-A inhibitors (see sect
Eintrag öffnenBrintellix · 4.5 · St. John’s wort Concomitant use of antidepressants with serotonergic effect and herbal remedies containing St.
Eintrag öffnenBrintellix · 4.5 · St. John’s wort Concomitant use of antidepressants with serotonergic effect and herbal remedies containing St.
Eintrag öffnenBriumvi · 4.5 · It is not recommended to use other immunosuppressives concomitantly with ublituximab except corticosteroids fo
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Concomitant treatment with levetiracetam In the clinical studies, although the numbers were limited, there was
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Concomitant treatment with levetiracetam In the clinical studies, although the numbers were limited, there was
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Concomitant treatment with levetiracetam In the clinical studies, although the numbers were limited, there was
Eintrag öffnenBronchitol · 4.5 · There are no data on concomitant use of hypertonic saline with Bronchitol as it was excluded from the Phase 3
Eintrag öffnenBrukinsa · 4.5 · Concomitant use of BRUKINSA and medicinal products that strongly or moderately inhibit CYP3A can increase zanu
Eintrag öffnenBrukinsa · 4.5 · Concomitant use of BRUKINSA and medicinal products that strongly or moderately inhibit CYP3A can increase zanu
Eintrag öffnenBrukinsa · 4.5 · Concomitant use of zanubrutinib and strong or moderate inducers of CYP3A can decrease zanubrutinib plasma conc
Eintrag öffnenBrukinsa · 4.5 · Concomitant use of zanubrutinib and strong or moderate inducers of CYP3A can decrease zanubrutinib plasma conc
Eintrag öffnenBrukinsa · 4.5 · Zanubrutinib is a mild inducer of CYP3A and CYP2C19. Concomitant use of zanubrutinib can decrease the plasma c
Eintrag öffnenBrukinsa · 4.5 · Zanubrutinib is a mild inducer of CYP3A and CYP2C19. Concomitant use of zanubrutinib can decrease the plasma c
Eintrag öffnenBusulfan Fresenius Kabi · 4.5 · Increases in busulfan exposure have been observed at concomitant administration of busulfan and deferasirox. T
Eintrag öffnen